UPDATE 1-Sixth trial of potential Chinese COVID-19 shot begins with GSK, Dynavax mix
June 19, 2020 at 04:52 AM EDT
A sixth experimental COVID-19 vaccine from China is now being tested in humans after Clover Biopharmaceuticals said on Friday an early-stage study of its candidate was underway with vaccine boosters from UK's GSK and U.S. based Dynavax.
